Medtronic plc (2M6.DE) XETRA

83.11

+0.56(+0.68%)

Updated at October 22 05:35PM

Currency In EUR

Medtronic plc

Address

20 On Hatch

Galway, 2

Ireland

Phone

353 1 438 1700

Sector

Healthcare

Industry

Medical - Devices

Employees

95000

First IPO Date

December 28, 2007

Key Executives

NameTitlePayYear Born
Mr. Geoffrey Straub MarthaChairman of the Board & Chief Executive Officer3.17M1970
Mr. Sean M. SalmonExecutive Vice President & President of Cardiovascular Portfolio1.5M1965
Mr. Brett A. WallExecutive Vice President & President of Neuroscience Portfolio1.56M1966
Mr. Gregory L. SmithExecutive Vice President of Global Operations & Supply Chain1.56M1964
Mr. Thierry PietonExecutive Vice President & Chief Financial Officer01970
Mr. Mark PloofSenior Vice President of Global Operations and Business Services0N/A
Dr. Kenneth E. Washington Ph.D.Senior Vice President and Chief Technology & Innovation Officer01960
Mr. Gary CoronaSenior Vice President of Corporate Finance0N/A
Dr. Laura Mauri M.D., M.Sc.Senior Vice President and Chief Scientific & Medical Officer0N/A
Ms. Denise L. BlomquistGlobal Controller & Principal Accounting Officer0N/A

Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.